When it is expressed by HCC tumor cells, which is about 70% of the time [22], alpha-fetoprotein (AFP) is an excellent biomarker for monitoring HCC progression, recurrence, and response to therapy; it is an effective prognosticator of HCC behavior [23,24,25]. Here, AFP is linked to neoplasm.